Newsroom

CAMPBELL, Califórnia--(BUSINESS WIRE)--A OXMIQ Labs Inc., empresa de arquitetura unificada de GPU e IA fundada por Raja Koduri, concluiu hoje sua rodada de financiamento Série A de US$ 35 milhões, elevando o capital total captado pela empresa para US$ 60 milhões. O financiamento permitirá a expansão do OxCore™, a arquitetura de GPU licenciável da OXMIQ que permite que empresas de semicondutores e construtores de sistemas de IA criem silício de IA personalizado sem a necessidade de um programa c...

NEW YORK--(BUSINESS WIRE)--Pershing Square Inc. (NYSE:PS) (“Pershing Square” or the “Company”) today announced that its Board of Directors has declared a quarterly cash dividend of $0.122 per share of its common stock for the third quarter of 2026, payable on July 21, 2026 to shareholders of record as of the close of business on July 13, 2026. This cash dividend marks Pershing Square’s first quarterly cash dividend since its initial public offering. The declaration and amount of any future quar...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of 399,750 restricted stock units to 30 new employees and the grant of stock options to purchase 91,000 shares of its common stock to one new employee. The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employee’s acceptance of employment wit...

CENTER VALLEY, Pa.--(BUSINESS WIRE)--Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR), announced today, in connection with the 10,000,000 shares of 6% Series A Mandatory Convertible Preferred Stock issued on May 5, 2025, consistent with the terms laid out in the offering, the Board of Directors has declared a dividend of $1.50 per share to be paid in cash on August 3, 2026 to holders of record as of the close of business on July 15, 2026. Subject to the terms of the Mandatory Conv...

BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)--GrafTech International Ltd. (NYSE:EAF) (the “Company”) will hold its Second Quarter 2026 Earnings Conference Call and Webcast on Friday, July 24, 2026 at 10:00 a.m. (EDT). The call will be hosted by senior management to discuss financial results for the second quarter ended June 30, 2026 and current business initiatives. These financial results will be released on Friday, July 24, 2026 before market open and will be available on our investor relations web...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--RiverNorth Capital and Income Fund, Inc. (the “Fund”) (NYSE: RSF), a closed-end fund, announced the final results of its repurchase offer for up to 5% of its outstanding common shares. The repurchase offer expired at 5:00 P.M. Eastern Time on July 1, 2026. Based on information provided by DST Systems, Inc., the depositary for the repurchase offer, a total of 1,791,867 shares were submitted for redemption and 181,965 shares were repurchased. In accordance...

BELLINGHAM, Washington--(BUSINESS WIRE)--SPIE, la société internationale de l’optique et de la photonique, invite les membres de la communauté de l’optique et de la photonique à poser leur candidature aux SPIE Prism Awards de cette année, qui récompensent de nouveaux produits exceptionnels qui révolutionnent le marché. Les lauréats seront annoncés lors de la cérémonie de remise des prix le 3 février 2027 au SPIE Photonics West à San Francisco, en Californie. Surnommés les « Oscars de la photoni...

フランス・リヨン--(BUSINESS WIRE)--（ビジネスワイヤ） -- Brenus Pharmaは、取締役会の主要人事を発表しました。同社は、エリック・デサーテン（Eric DESSERTENNE）をプレジデント兼取締役会会長に迎えました。同氏は、共同創業者であるジャック・ガルデット（Jacques GARDETTE）の後任です。ジャック・ガルデットは、引き続き取締役として活動します。エリック・デサーテンは、ヘルスケア分野のイノベーションと価値創造に関する豊富な経験を有しており、特にバイオコープ（BIOCORP）の成長、および同社がノボ ノルディスクに買収されるまでの過程を主導しました。Brenusはまた、カミラ・シルベスト（Camilla SYLVEST）を2人目の独立取締役に任命しました。今回の任命は、米国を拠点とする経験豊富なバイオテック業界の経営幹部兼起業家であるディアラ・エズディーン（Diala EZZEDDINE）を先に迎えたのに続くものです。 カミラ・シルベストは、製薬業界で豊富な経験を持つ経営幹部であり、グローバルに活躍するビジネス・リーダーです。ノボ ノル...

ST. GEORGE, Utah--(BUSINESS WIRE)--SkyWest, Inc. (NASDAQ: SKYW) will host a live conference call and webcast after the market closes on Thursday, July 23, 2026 to discuss second quarter 2026 results. The format will include an overview of the quarterly results followed by a Q&A session. Thursday, July 23, 2026 2:30 p.m. Mountain Time Interested parties can access the webcast at: https://events.q4inc.com/attendee/759519720 The call-in number for US callers is 1-888-330-2455 The call-in numbe...

LYON, Frankreich--(BUSINESS WIRE)--Brenus Pharma gab heute wichtige Ernennungen für sein Board of Directors bekannt. Das Unternehmen begrüßt Eric DESSERTENNE als President und Chairman des Board of Directors. Er tritt die Nachfolge des Mitbegründers Jacques GARDETTE an, der dem Board weiterhin als aktives Mitglied angehören wird. Eric verfügt über langjährige Erfahrungen im Bereich Innovation und Wertschöpfung im Gesundheitswesen und hat insbesondere BIOCORP während seiner gesamten Entwicklung...